Llwytho...

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia

BACKGROUND: Inhibitors of proprotein convertase subtilisin kexin 9 are indicated in Canada for treatment of patients with familial hypercholesterolemia (FH). Classically, FH is considered to be a monogenic condition caused by rare pathogenic mutations; however, some patients have hypercholesterolemi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:CJC Open
Prif Awduron: Lee, Timothy, Iacocca, Michael A., Ban, Matthew R., Hegele, Robert A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2019
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7063626/
https://ncbi.nlm.nih.gov/pubmed/32159093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjco.2019.02.005
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!